12283DEXTERITY-CIP0217OpenDEXTERITY-AFP: Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation after Thrombus Removal to Yield Benefit in Acute Femoropopliteal DVTThis is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available anti-inflammatory drug (dexamethasone sodium phosphate injection) around the deep veins after DVT recanalization, where DVT symptoms were present for up to 14 days prior to recanalization. The goal of the study is to see if local anti-inflammation helps prevent re-thrombosis of the blood vessel and improvement in symptoms for up to 24 months after the initial DVT recanalization procedure.NCT04862468IndustrialAdultTreatmentCombination Product: Perivascular dexamethasone
Combination Product: Perivascular shamIIOtherThis study identifies the following disease or conditions: Thrombosis, Deep Vein
Iliofemoral; ThrombosisAbramowitz, StevenMedstar Washington Hospital CenterMCRN - Peripheral Vascular2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>